UNIVERSITY OF CINCINNATI;CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
发明人:
Edward J. Merino,James C. Mulloy,Guorui Li,Tiffany Bell-Horwath
申请号：
US13782202
公开号：
US20130230542A1
申请日:
2013.03.01
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Provided are compounds according to the following Formula I:The Formula I compounds are activated in the presence of reactive oxygen species (ROS) and are therefore selective anti-cancer therapeutics for cancers associated with elevated ROS. Also provided are methods and pharmaceutical compositions for treating cancers associated with increased ROS.
